Home » Shanghai Pharma's IPO to top $2.1 billion
Shanghai Pharma's IPO to top $2.1 billion
May 13, 2011
Shanghai Pharmaceuticals has priced its proposed initial public offering in Hong Kong, which will top $2.13 billion, according to Pharma Times.
Shanghai Pharmaceuticals is China's second-largest distributor of pharmaceutical products and the country's third-largest drug manufacturer.
Standard Operating Procedures for Risk-Based Monitoring of Clinical Trials
Learn More Here